查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566903

影像导航放射治疗市场：按产品、程序和最终用户：2024-2033 年全球机会分析和产业预测

Image-Guided Radiation Therapy Market By Product, By Procedure (IMRT, Stereotactic Therapy, Particle Therapy, Others) By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

影像导航放射治疗市场

2023年影像导航放射治疗市场价值为19亿美元，预计2024年至2033年复合年增长率为5.7%，到2033年将达到33亿美元。

影像导航放射治疗是癌症治疗中常用的影像处理过程。这种治疗方法涉及多种影像技术，包括 MRI、PET 和电脑断层扫描，并可以精确定位放射线来杀死癌细胞。使用成像技术产生的高品质影像来实现精确瞄准。影像导引放射治疗已成为现代肿瘤学实践中必要的治疗方法，因为这种方法提高了治疗精度，改善了治疗结果，并减少了放射相关併发症。

影像导航放射治疗市场的关键驱动因素是多种癌症盛行率的增加以及对标靶癌症治疗的需求不断增加。此外，在治疗期间引入即时成像正在提高治疗效果并推动对影像导航放射治疗的需求。表面引导放射治疗由于其最先进的特性（例如配药内运动监测和呼吸门控）最近已在多个肿瘤中心广泛采用。

然而，与影像导航放射治疗相关的设备采购成本和患者治疗成本高昂是市场的主要限制。相反，技术的进步正在使治疗领域多样化并完善治疗过程。人工智慧和机器学习的融合使得能够根据患者的生命征象和需求提供个人化的癌症治疗。例如，对于胶质母细胞瘤患者，使用基于人工智慧的剂量优化软体来调整放射治疗。这涉及提供最佳剂量的辐射，以最大限度地抑制肿瘤，同时保护大脑的重要部分，例如脑干和视神经。

按部门审查

影像导航放射治疗市场分为产品、程序、最终用户和区域。依产品分为4D RT、直线加速器、MRI引导放射治疗、射野成像及电脑断层扫描。依技术分为IMRT（强度调控放射治疗）、立体定位治疗、粒子束治疗等。依最终使用者分为医院、独立放射治疗中心等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

从产品来看，直线加速器在市场上占据主导地位。

从手术方式来看，IMRT（强度调控放射治疗）处于市场领先地位。

按地区划分，预计到 2033 年，北美地区的收益将最高。

该报告可以定制。

  • 根据客户兴趣加入公司简介

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章影像导引放射治疗市场：副产品

  • 市场概况
  • 4D RT
  • 直线加速器
  • MRI导引放射治疗
  • 门静脉成像
  • 电脑断层扫描

第五章影像导航放射治疗市场：依程序

  • 市场概况
  • IMRT（强度调控放射治疗）
  • 立体定位放射治疗
  • 粒子束治疗
  • 其他的

第六章影像导航放射治疗市场：依最终使用者分类

  • 市场概况
  • 医院
  • 独立放射治疗中心
  • 其他的

第七章影像导引放射治疗市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国影像导航放射治疗市场
    • 加拿大影像导航放射治疗市场
    • 墨西哥影像导航放射治疗市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国影像导航放射治疗市场
    • 德国影像导航放射治疗市场
    • 义大利影像导航放射治疗市场
    • 西班牙影像导航放射治疗市场
    • 英国影像导航放射治疗市场
    • 其他欧洲国家影像导航放射治疗市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国影像导航放射治疗市场
    • 日本影像导航放射治疗市场
    • 印度影像导航放射治疗市场
    • 韩国影像导航放射治疗市场
    • 澳洲影像导航放射治疗市场
    • 其他亚太影像导航放射治疗市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西影像导航放射治疗市场
    • 南非影像导航放射治疗市场
    • 沙乌地阿拉伯的影像导航放射治疗市场
    • 其他拉丁美洲/中东/非洲影像导航放射治疗市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Varian Medical Systems, Inc.
  • Elekta AB, Accuray Incorporated
  • ViewRay, Inc.
  • Siemens Healthineers AG
  • Hitachi, Ltd
  • Brainlab AG
  • MEVION MEDICAL SYSTEMS, INC.
  • C-Rad AB
  • Sumitomo Heavy Industries, Ltd.
  • Philips Healthcare
简介目录
Product Code: A323701

Image-guided Radiation Therapy Market

The image-guided radiation therapy market was valued at $1.9 billion in 2023 and is projected to reach $3.3 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Image-guided radiation therapy is a frequent imaging process used in the treatment of cancer. The therapy involves several imaging techniques such as MRI, PET, and CT scans, which allow for precise targeting of radiation for killing the cancer cells. The precise targeting is performed using the high-quality images generated by imaging technologies. This approach elevates the accuracy of treatment, improves therapy outcomes, and reduces radiation-related complications, making image-guided radiation therapy a necessary procedure in modern oncology practice.

Increase in prevalence of diverse forms of cancers and rise in demand for targeted cancer treatment are the major drivers of the image-guided radiation therapy market. In addition, the deployment of real-time imaging during ongoing treatment sessions has boosted the efficacy of treatment, thereby boosting the demand for image-guided radiation therapy. Surface-guided radiation therapy has recently witnessed widespread adoption in several oncology facilities due to its cutting-edge attributes such as intra-fraction motion monitoring and respiratory gating.

However, the cost associated with procuring instruments related to image-guided radiation therapy, along with the high costs of treatment for the patients, is a major restraint for the market. On the contrary, enhancements in technology are diversifying the prospects of the therapy and refining the healing process. Assimilation of AI and ML is enabling the delivery of personalized cancer treatment according to the vitals and requirements of the patient. For instance, in the case of a patient suffering from glioblastoma, an AI-based dose optimization software was used to tailor the radiation therapy. This included the delivery of optimal dose of radiation, resulting in maximum tumor control while guarding the pivotal parts of the brain such as brainstem and optic nerves.

Segment Review

The image-guided radiation therapy market is segmented into product, procedure, end user, and region. On the basis of product, the market is divided into 4D RT, LINAC, MRI-guided radiotherapy, portal imaging, and CT scanning. By procedure, it is classified into IMRT (intensity modulation radiation therapy), stereotactic therapy, particle therapy, and others. Depending on end user, it is categorized into hospitals, independent radiotherapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the LINAC segment dominates the market.

By procedure, the IMRT (intensity modulation radiation therapy) segment is the leader in the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global image-guided radiation therapy market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, ViewRay, Inc., Siemens Healthineers AG, Hitachi, Ltd, Brainlab AG, MEVION MEDICAL SYSTEMS, INC., C-Rad AB, Sumitomo Heavy Industries, Ltd., and Philips Healthcare. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Product

  • 4D RT
  • LINAC
  • MRI-guided Radiotherapy
  • Portal Imaging
  • CT Scanning

By Procedure

  • IMRT (intensity modulation radiation therapy)
  • Stereotactic Therapy
  • Particle Therapy
  • Others

By End User

  • Hospitals
  • Independent Radiotherapy Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Varian Medical Systems, Inc.
    • Elekta AB, Accuray Incorporated
    • ViewRay, Inc.
    • Siemens Healthineers AG
    • Hitachi, Ltd
    • Brainlab AG
    • MEVION MEDICAL SYSTEMS, INC.
    • C-Rad AB
    • Sumitomo Heavy Industries, Ltd.
    • Philips Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. 4D RT
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. LINAC
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. MRI-guided Radiotherapy
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Portal Imaging
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. CT Scanning
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PROCEDURE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Procedure
  • 5.2. IMRT (intensity Modulation Radiation Therapy)
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Stereotactic Therapy
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Particle Therapy
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: IMAGE-GUIDED RADIATION THERAPY MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Independent Radiotherapy Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Procedure
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Image-Guided Radiation Therapy Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Procedure
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Image-Guided Radiation Therapy Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Procedure
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Image-Guided Radiation Therapy Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Procedure
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Procedure
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Image-Guided Radiation Therapy Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Procedure
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Image-Guided Radiation Therapy Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Procedure
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Image-Guided Radiation Therapy Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Procedure
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Image-Guided Radiation Therapy Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Procedure
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Image-Guided Radiation Therapy Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Procedure
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Image-Guided Radiation Therapy Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Procedure
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Procedure
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Image-Guided Radiation Therapy Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Procedure
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Image-Guided Radiation Therapy Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Procedure
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Image-Guided Radiation Therapy Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Procedure
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Image-Guided Radiation Therapy Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Procedure
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Image-Guided Radiation Therapy Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Procedure
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Image-Guided Radiation Therapy Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Procedure
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Procedure
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Image-Guided Radiation Therapy Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Procedure
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Image-Guided Radiation Therapy Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Procedure
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Image-Guided Radiation Therapy Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Procedure
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Image-Guided Radiation Therapy Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Procedure
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Varian Medical Systems, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Elekta AB, Accuray Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. ViewRay, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Siemens Healthineers AG
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Hitachi, Ltd
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Brainlab AG
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. MEVION MEDICAL SYSTEMS, INC.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. C-Rad AB
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Sumitomo Heavy Industries, Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Philips Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments